SPRYCEL (dasatinib) Patient Assistance Program
Don’t let the high cost of brand specialty leukemia therapy stand between you and the treatment you need. We help eligible patients access Sprycel (dasatinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Sprycel (dasatinib) is FDA-approved for adults and pediatric patients aged 1 year and older with newly diagnosed Ph+ chronic-phase chronic myeloid leukemia (CML), for adults with Ph+ chronic-phase, accelerated-phase, or blast-phase CML who have resistance or intolerance to prior therapy, and for adults with Ph+ acute lymphoblastic leukemia (ALL).
- Without assistance, the brand list price commonly runs $19,400–$22,000 per 30 tablets at the standard 100 mg daily dose.
- Generic dasatinib launched in late 2023/early 2024 and is now widely available; publicly listed coupon prices for the generic at major pharmacies are as low as $820–$900 per 30-tablet supply — far below brand pricing.
- Through AffordMyPrescriptions, qualifying patients can access Sprycel (or generic dasatinib) for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
What is Sprycel Prescription Assistance Program?
The Sprycel Prescription Assistance Program is a manufacturer-sponsored initiative that provides Sprycel at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for leukemia patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries who cannot afford brand specialty therapy.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, BCR-ABL testing documentation, specialty pharmacy logistics, and renewal deadlines — all while managing a chronic leukemia.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, brand Sprycel costs roughly $19,400–$22,000 per 30 tablets. Generic dasatinib has dramatically changed the landscape — available at $820–$900 with coupons. Many patients should consider the generic path first; if you specifically need brand, our PAP service applies:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$21,500.00 | Save ~$21,430/mo |
| CVS Pharmacy | ~$22,000.00 | Save ~$21,930/mo |
| Walmart | ~$19,800.00 | Save ~$19,730/mo |
| Costco | ~$19,400.00 | Save ~$19,330/mo |
| Generic dasatinib (low) | ~$820.00 | Save ~$750/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Sprycel Prescription Program?
The Patient Assistance Program is free to apply for and provides Sprycel at little or no medication cost if approved. But the process involves detailed applications, oncology-team coordination, BCR-ABL documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment. Note: with generic dasatinib now widely available at ~$820–$900/mo, we may recommend the generic path if it is the better fit for you.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Sprycel:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $19,400–$22,000 (brand) / $820–$900 (generic) per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Sprycel assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Sprycel Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Sprycel:
Sprycel (dasatinib) is an oral targeted oncology medicine used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) in adults and children. It belongs to a class of medicines called tyrosine kinase inhibitors (TKIs) and is taken as a single oral tablet once daily.
How It Works:
Sprycel targets the BCR-ABL fusion protein, an overactive enzyme caused by a genetic swap between chromosomes 9 and 22. This protein normally signals the bone marrow to overproduce abnormal white blood cells, which eventually crowd out healthy blood production. By blocking this and related kinases, Sprycel shuts down the growth signal and allows the bone marrow to return to a more normal function.
Form and Use:
The medication is an oral tablet taken once daily, with the standard adult dose being 100 mg for chronic-phase CML and 140 mg for more advanced cases. Pediatric doses are determined by a physician based on the child’s weight. Tablets must be swallowed whole and can be taken at any time of day, either with or without food.
Generic Availability:
Generic dasatinib is FDA-approved and widely available in the U.S. following its launch in late 2023 and early 2024. Multiple manufacturers now offer the drug at significantly reduced prices compared to the brand-name version, with some costs dropping as low as $820–$900 for a month’s supply. While other similar inhibitors exist, your oncology team will determine which specific medication is best for your treatment.
Warnings:
Sprycel carries risks for low blood counts, serious bleeding, and fluid retention around the heart or lungs. It can also lead to pulmonary arterial hypertension, heart rhythm changes (QT prolongation), and severe skin reactions. To manage these risks, oncology teams perform regular blood tests and lab work to adjust dosages as necessary.
FAQ (Frequently Asked Questions)
How Much Does Sprycel Cost Without Insurance?
The brand list price commonly runs $19,400–$22,000 per 30 tablets at the standard 100 mg daily dose. Generic dasatinib is dramatically cheaper — as low as $820–$900 per 30-tablet supply at major pharmacies with coupons. Through AffordMyPrescriptions, qualifying patients receive Sprycel (or generic dasatinib) at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Is Generic Dasatinib The Same Medicine?
Yes. Generic dasatinib is FDA-approved as bioequivalent to brand Sprycel and is now widely available at major pharmacies. The active ingredient, indications, and dosing are the same. We mention this directly because for many patients, generic dasatinib at major-pharmacy coupon prices ($820–$900) is so much cheaper than brand Sprycel that it may be the better path even before considering our service.
Are There Other TKI Options I Should Know About?
Yes. Several other tyrosine kinase inhibitors are FDA-approved for Ph+ CML and Ph+ ALL, including imatinib (which has been generic for years and is typically the cheapest TKI), nilotinib, bosutinib, ponatinib, and asciminib. Whether any of these is a better clinical fit depends on the disease phase, prior treatments, BCR-ABL mutation status, and tolerability. We mention this because if a different TKI would work for you and is cheaper, that may be a better long-term path.
Can I Get Sprycel Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Sprycel Patient Assistance. However, with generic dasatinib widely available at low cost, many Medicare patients can simply fill the generic at their pharmacy without needing PAP advocacy at all. Our advocates will help you find the most cost-effective path.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including switching to generic dasatinib at a major pharmacy with a coupon, the manufacturer’s copay assistance program if you have commercial insurance, independent foundations such as the PAN Foundation, HealthWell Foundation, or the Leukemia & Lymphoma Society Co-Pay Assistance Program, or asking your oncology team whether a different TKI on a more accessible cost path would be appropriate. If we cannot find a path, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients receive their first Sprycel (or generic dasatinib) shipment within two to four weeks of completing the documentation. Timing depends on how quickly your oncology team returns the required forms and the pharmacy processes your prescription.
Take Control of Your Medication Costs
If you are struggling with the high cost of Sprycel, our team may be able to help you access assistance programs designed to make brand leukemia therapy affordable — or guide you to the much cheaper generic dasatinib path if it is the better fit. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.